Observational study of lymphoma patients in Bologna
Italian Prospective Observational Cohort Study of Patients With Lymphoma
IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06814925
This study is looking to gather information from 1500 lymphoma patients in Bologna to see how genetics, treatments, and lifestyle affect their health and quality of life over time.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1500 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | IRCCS Azienda Ospedaliero-Universitaria di Bologna (other) |
| Locations | 1 site (Bologna, Bologna) |
| Trial ID | NCT06814925 on ClinicalTrials.gov |
What this trial studies
This observational study aims to enroll 1500 patients diagnosed with lymphoma within three months of enrollment at the Institute of Hematology 'Seragnoli' over a five-year period. The study will collect data on genetic and epidemiological factors, treatment types, and lifestyle influences on disease progression. Patients will complete questionnaires at baseline and during follow-up to assess the impact of lymphoma on their quality of life and to support future research initiatives.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older who have been diagnosed with lymphoma within the last three months.
Not a fit: Patients who were diagnosed with lymphoma more than three months prior to enrollment may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance understanding of lymphoma and improve patient management strategies.
How similar studies have performed: While this study is observational and builds on existing knowledge, similar studies have successfully identified factors influencing lymphoma outcomes.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age greater than or equal to 18 years at enrollment * Diagnosis of lymphoma within 3 months of enrollment * Patients may have been treated, as long as the initial diagnosis of lymphoma is within 3 months of enrollment * Signing of the informed consent form Exclusion Criteria: * none
Where this trial is running
Bologna, Bologna
- IRCCS Azienda Ospedaliero - Universitaria di Bologna — Bologna, Bologna, Italy (RECRUITING)
Study contacts
- Principal investigator: Pier Luigi Zinzani, MD — IRCCS Azienda Ospedaliero-Universitaria di Bologna
- Study coordinator: Pier Luigi Zinzani, MD
- Email: pierluigi.zinzani@unibo.it
- Phone: +390512143680
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Lymphoma, questionnaire